Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.82)
# 1,947
Out of 5,105 analysts
26
Total ratings
62.5%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $493.99 | -30.36% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $21.80 | +145.41% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $31.35 | +27.59% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $33.38 | -10.13% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $6.21 | +36.88% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $21.36 | -25.09% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.14 | +50,063.93% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $1.06 | +43,296.23% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.17 | +1,508.83% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $42.11 | -62.00% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $5.70 | +689.47% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $493.99
Upside: -30.36%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $21.80
Upside: +145.41%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $31.35
Upside: +27.59%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $33.38
Upside: -10.13%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $6.21
Upside: +36.88%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $21.36
Upside: -25.09%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.14
Upside: +50,063.93%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $1.06
Upside: +43,296.23%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.17
Upside: +1,508.83%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $42.11
Upside: -62.00%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $5.70
Upside: +689.47%